T1	Participants 47 91	patients insufficiently controlled on timolo
T2	Participants 230 341	in patients with open angle glaucoma or ocular hypertension where IOP is not adequately controlled with timolol
T3	Participants 416 569	53 patients with primary open angle glaucoma, capsular glaucoma, or ocular hypertension with an IOP of at least 21 mmHg on current therapy were recruited
